Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

被引：0
作者：
Romuald Bellmann
Piotr Smuszkiewicz
机构：
[1] Medical University of Innsbruck,Clinical Pharmacokinetics Unit, Division of Intensive Care and Emergency Medicine, Department of Internal Medicine I
[2] University Hospital,Department of Anesthesiology, Intensive Therapy and Pain Treatment
来源：
Infection | 2017年 / 45卷
关键词：
Polyenes; Amphotericin B lipid formulations; Liposomal amphotericin B; Itraconazole; Voriconazole; Echinocandins; Caspofungin; Critically ill; Renal replacement therapy; Extracorporeal membrane oxygenation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：737 / 779
页数：42
相关论文
共 2034 条
  • [1] Meersseman W(2004)Invasive aspergillosis in critically ill patients without malignancy Am J Respir Crit Care Med 170 621-625
  • [2] Vandecasteele SJ(2004)Disposition of posaconazole following single-dose oral administration in healthy subjects Antimicrob Agents Chemother 48 3543-3551
  • [3] Wilmer A(2012)Plasma pharmacokinetics of antimicrobial agents in critically ill patients Curr Clin Pharmacol. 8 5-12
  • [4] Verbeken E(2011)Antifungal PK/PD considerations in fungal pulmonary infections Semin Respir Crit Care Med. 32 783-794
  • [5] Peetermans WE(2014)Tissue penetration of antifungal agents Clin Microbiol Rev 27 68-88
  • [6] Van Wijngaerden E(1958)Amphotericin B: intravenous use in 21 patients with systemic fungal diseases Antibiot Annu. 6 628-634
  • [7] Krieter P(2005)Amphotericin B Appl Microbiol Biotechnol 68 151-162
  • [8] Flannery B(1996)Carrier effects on biological activity of amphotericin B Clin Microbiol Rev 9 512-531
  • [9] Musick T(2002)Amphotericin B: spectrum and resistance J Antimicrob Chemother 49 7-10
  • [10] Gohdes M(2016)Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America Clin Infect Dis 63 e1-e60
12345678910